2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Human Influenza: new trials by email Literature Review of Human Influenza trials Research Report on Human Influenza
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Universal Influenza A Vaccine in Healthy Adults UFluA 20 µg each antigen/dose, UFluA 60 µg each antigen/dose, Placebo - Human Influenza | Phase 1 | Completed | Emergent BioSolutions | 27 | 2021-12-01 | 2025-01-20 |
| Safety of 4Fluart ID Suspension for Injection in Adult Subjects 4Fluart ID suspension for injection study drug 1 µg/0.1 ml, influenza vaccine (whole virion, inactivated, adjuvanted), 4Fluart ID suspension for injection study drug 2 µg/0.1 ml, influenza vaccine (whole virion, inactivated, adjuvanted), 3Fluart suspension for injection, influenza vaccine (whole virion, inactivated, adjuvanted) - Human Influenza | Phase 1 | Completed | Fluart Innovative Vaccine Ltd, Hungary | 36 | 2018-01-31 | 2021-03-03 |
Influenza, Human (2)
Infections (2) · Orthomyxoviridae Infections (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Virus Diseases (2)
Influenza Vaccines (1) · Injections (1)
Emergent BioSolutions (1) · Fluart Innovative Vaccine Ltd, Hungary (1)
Australia (1) · Hungary (1)